{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:59:01Z","timestamp":1794322741396,"version":"4.9.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T00:00:00Z","timestamp":1686441600000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s40121-023-00826-w","type":"journal-article","created":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T15:01:26Z","timestamp":1686495686000},"page":"1695-1713","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan"],"prefix":"10.1007","volume":"12","author":[{"given":"Motoyuki","family":"Sugai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3699-7231","authenticated-orcid":false,"given":"Akira","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Vasilopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Kurosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Taie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,11]]},"reference":[{"issue":"4","key":"826_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jiph.2016.08.007","volume":"10","author":"M Frieri","year":"2017","unstructured":"Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017;10(4):369\u201378.","journal-title":"J Infect Public Health"},{"issue":"2","key":"826_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7883\/yoken.JJID.2020.499","volume":"74","author":"T Kajihara","year":"2021","unstructured":"Kajihara T, Yahara K, Hirabayashi A, Shibayama K, Sugai M. Japan nosocomial infections surveillance (JANIS): current status, international collaboration, and future directions for a comprehensive antimicrobial resistance surveillance system. Jpn J Infect Dis. 2021;74(2):87\u201396.","journal-title":"Jpn J Infect Dis"},{"key":"826_CR3","unstructured":"World Health Organization. Global action plan on antimicrobial resistance 2015. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241509763. Accessed 1 Apr 2023."},{"key":"826_CR4","unstructured":"The Government of Japan. National Action Plan on Antimicrobial Resistance (AMR) 2016\u20132020. Available from: https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10900000-Kenkoukyoku\/0000138942.pdf. Accessed 1 Apr 2023."},{"key":"826_CR5","unstructured":"World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) report: 2022. Available from: https:\/\/www.who.int\/initiatives\/glass. Accessed 1 Apr 2023."},{"key":"826_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25122888","author":"B Jubeh","year":"2020","unstructured":"Jubeh B, Breijyeh Z, Karaman R. Resistance of gram-positive bacteria to current antibacterial agents and overcoming approaches. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25122888.","journal-title":"Molecules"},{"issue":"3","key":"826_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327.","journal-title":"Lancet Infect Dis"},{"key":"826_CR8","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States 2019. Available from: https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf. Accessed 1 Apr 2023."},{"key":"826_CR9","unstructured":"Japan Agency for Medical Research and Development (AMED). Priority Pathogens Lists for R&D of New Antibiotics (2021 version). 2022. Available from: https:\/\/id3catalyst.jp\/apid\/en\/list.html. Accessed 1 Apr 2023."},{"issue":"4","key":"826_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1128\/CMR.13.4.686","volume":"13","author":"Y Cetinkaya","year":"2000","unstructured":"Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13(4):686\u2013707.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"826_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jmii.2017.08.025","volume":"51","author":"JJ Ye","year":"2018","unstructured":"Ye JJ, Shie SS, Cheng CW, Yang JH, Huang PY, Wu TS, et al. Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia. J Microbiol Immunol Infect. 2018;51(6):705\u201316.","journal-title":"J Microbiol Immunol Infect"},{"key":"826_CR12","volume-title":"Vancomycin-resistant enterococci","author":"M Levitus","year":"2022","unstructured":"Levitus M, Rewane A, Perera TB. Vancomycin-resistant enterococci. StatPearls: StatPearls Publishing; 2022."},{"issue":"4","key":"826_CR13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.idc.2020.08.004","volume":"34","author":"WR Miller","year":"2020","unstructured":"Miller WR, Murray BE, Rice LB, Arias CA. Resistance in vancomycin-resistant enterococci. Infect Dis Clin North Am. 2020;34(4):751\u201371.","journal-title":"Infect Dis Clin North Am"},{"key":"826_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00811-8","author":"RPJ Willems","year":"2023","unstructured":"Willems RPJ, van Dijk K, Vehreschild M, Biehl LM, Ket JCF, Remmelzwaal S, et al. Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis. Lancet Infect Dis. 2023. https:\/\/doi.org\/10.1016\/S1473-3099(22)00811-8.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"826_CR15","volume":"5","author":"C Gorrie","year":"2019","unstructured":"Gorrie C, Higgs C, Carter G, Stinear TP, Howden B. Genomics of vancomycin-resistant Enterococcus faecium. Microb Genom. 2019;5(7): e000283.","journal-title":"Microb Genom"},{"key":"826_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-130","author":"A Kramer","year":"2006","unstructured":"Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006. https:\/\/doi.org\/10.1186\/1471-2334-6-130.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"826_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/668770","volume":"34","author":"DM Sievert","year":"2013","unstructured":"Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010. Infect Control Hosp Epidemiol. 2013;34(1):1\u201314.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 1","key":"826_CR18","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1086\/514910","volume":"27","author":"GL French","year":"1998","unstructured":"French GL. Enterococci and vancomycin resistance. Clin Infect Dis. 1998;27(Suppl 1):S75-83.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"826_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/430909","volume":"41","author":"CA DiazGranados","year":"2005","unstructured":"DiazGranados CA, Zimmer SM, Mitchel K, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327\u201333.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"826_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhin.2019.12.007","volume":"105","author":"C MacDougall","year":"2020","unstructured":"MacDougall C, Johnstone J, Prematunge C, Adomako K, Nadolny E, Truong E, et al. Economic evaluation of vancomycin-resistant enterococci (VRE) control practices: a systematic review. J Hosp Infect. 2020;105(1):53\u201363.","journal-title":"J Hosp Infect"},{"key":"826_CR21","unstructured":"National Institute of Infectious Diseases. Infectious Agents Surveillance Report (IASR) 2021. 42(8):155\u2013167. Available from: https:\/\/www.niid.go.jp\/niid\/ja\/vre-m\/vre-iasrtpc\/10589-498t.html. Accessed 1 Apr 2023."},{"key":"826_CR22","unstructured":"Japan Nosocomial Infections Surveillance. Annual Open Report 2020 (All Facilities). Available from: https:\/\/janis.mhlw.go.jp\/english\/report\/index.html. Accessed 1 Apr 2023."},{"key":"826_CR23","unstructured":"European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe, 2020 data. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Surveillance-antimicrobial-resistance-in-Europe-2020.pdf. Accessed 1 Apr 2023."},{"issue":"1","key":"826_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ice.2019.296","volume":"41","author":"LM Weiner-Lastinger","year":"2020","unstructured":"Weiner-Lastinger LM, Abner S, Edwards JR, Kallen AJ, Karlsson M, Magill SS, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015\u20132017. Infect Control Hosp Epidemiol. 2020;41(1):1\u201318.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"826_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1089\/mdr.2017.0147","volume":"24","author":"MO Ahmed","year":"2018","unstructured":"Ahmed MO, Baptiste KE. Vancomycin-resistant enterococci: a review of antimicrobial resistance mechanisms and perspectives of human and animal health. Microb Drug Resist. 2018;24(5):590\u2013606.","journal-title":"Microb Drug Resist"},{"issue":"6","key":"826_CR26","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/jac\/dky074","volume":"73","author":"SJ van Hal","year":"2018","unstructured":"van Hal SJ, Beukers AG, Timms VJ, Ellem JA, Taylor P, Maley MW, et al. Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation. J Antimicrob Chemother. 2018;73(6):1487\u201391.","journal-title":"J Antimicrob Chemother"},{"key":"826_CR27","doi-asserted-by":"publisher","first-page":"21847","DOI":"10.1038\/srep21847","volume":"6","author":"JK Bender","year":"2016","unstructured":"Bender JK, Kalmbach A, Fleige C, Klare I, Fuchs S, Werner G. Population structure and acquisition of the vanB resistance determinant in German clinical isolates of Enterococcus faecium ST192. Sci Rep. 2016;6:21847.","journal-title":"Sci Rep"},{"issue":"12","key":"826_CR28","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1093\/jac\/dkw314","volume":"71","author":"GP Carter","year":"2016","unstructured":"Carter GP, Buultjens AH, Ballard SA, Baines SL, Tomita T, Strachan J, et al. Emergence of endemic MLST non-typeable vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother. 2016;71(12):3367\u201371.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"826_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218185","volume":"14","author":"K Lemonidis","year":"2019","unstructured":"Lemonidis K, Salih TS, Dancer SJ, Hunter IS, Tucker NP. Emergence of an Australian-like pstS-null vancomycin resistant Enterococcus faecium clone in Scotland. PLoS One. 2019;14(6): e0218185.","journal-title":"PLoS One"},{"issue":"7","key":"826_CR30","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s10096-020-03853-4","volume":"39","author":"HM Kim","year":"2020","unstructured":"Kim HM, Chung DR, Cho SY, Huh K, Kang CI, Peck KR. Emergence of vancomycin-resistant Enterococcus faecium ST1421 lacking the pstS gene in Korea. Eur J Clin Microbiol Infect Dis. 2020;39(7):1349\u201356.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"826_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13073-021-00868-0","volume":"13","author":"SJ van Hal","year":"2021","unstructured":"van Hal SJ, Willems RJL, Gouliouris T, Ballard SA, Coque TM, Hammerum AM, et al. The global dissemination of hospital clones of Enterococcus faecium. Genome Med. 2021;13(1):52.","journal-title":"Genome Med"},{"issue":"1","key":"826_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13756-022-01136-5","volume":"11","author":"N Saito","year":"2022","unstructured":"Saito N, Kitazawa J, Horiuchi H, Yamamoto T, Kimura M, Inoue F, et al. Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan. Antimicrob Resist Infect Control. 2022;11(1):99.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"12","key":"826_CR33","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jiac.2021.08.004","volume":"27","author":"D Kitagawa","year":"2021","unstructured":"Kitagawa D, Komatsu M, Nakamura A, Suzuki S, Oka M, Masuo K, et al. Nosocomial infections caused by vancomycin-resistant Enterococcus in a Japanese general hospital and molecular genetic analysis. J Infect Chemother. 2021;27(12):1689\u201393.","journal-title":"J Infect Chemother"},{"issue":"11","key":"826_CR34","first-page":"1243","volume":"64","author":"S Takakura","year":"2016","unstructured":"Takakura S. Vancomycin-resistant enterococci. Rinsho Byori. 2016;64(11):1243\u20138.","journal-title":"Rinsho Byori"},{"issue":"6","key":"826_CR35","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10096-011-1412-x","volume":"31","author":"A Matsushima","year":"2012","unstructured":"Matsushima A, Takakura S, Yamamoto M, Matsumura Y, Shirano M, Nagao M, et al. Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan. Eur J Clin Microbiol Infect Dis. 2012;31(6):1095\u2013100.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"826_CR36","unstructured":"National Institute of Infectious Diseases. Infectious. Infectious Agents Surveillance Report (IASR). 2021. 42(5):100\u2013101. Available from: https:\/\/www.niid.go.jp\/niid\/ja\/vre-m\/vre-iasrs\/10264-495p01.html. Accessed 1 Apr 2023."},{"issue":"5","key":"826_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1086\/502213","volume":"24","author":"CA Muto","year":"2003","unstructured":"Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003;24(5):362\u201386.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10 Suppl 2","key":"826_CR38","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1016\/j.ajic.2007.10.006","volume":"35","author":"JD Siegel","year":"2007","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165\u201393.","journal-title":"Am J Infect Control"},{"issue":"8","key":"826_CR39","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s40273-020-00906-6","volume":"38","author":"J Gordon","year":"2020","unstructured":"Gordon J, Darlington O, McEwan P, Lumley M, Taie A, Hicks M, et al. Estimating the value of new antimicrobials in the context of antimicrobial resistance: development and application of a dynamic disease transmission model. Pharmacoeconomics. 2020;38(8):857\u201369.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"826_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.36469\/jheor.2021.28327","volume":"8","author":"T Matsumoto","year":"2021","unstructured":"Matsumoto T, Darlington O, Miller R, Gordon J, McEwan P, Ohashi T, et al. Estimating the economic and clinical value of reducing antimicrobial resistance to three gram-negative pathogens in Japan. J Health Econ Outcomes Res. 2021;8(2):64\u201375.","journal-title":"J Health Econ Outcomes Res"},{"issue":"1","key":"826_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s41669-022-00368-w","volume":"7","author":"T Matsumoto","year":"2023","unstructured":"Matsumoto T, Yuasa A, Miller R, Pritchard C, Ohashi T, Taie A, et al. Estimating the economic and clinical value of introducing ceftazidime\/avibactam into antimicrobial practice in Japan: a dynamic modelling study. Pharmacoecon Open. 2023;7(1):65\u201376.","journal-title":"Pharmacoecon Open"},{"issue":"1","key":"826_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","volume":"25","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Value Health. 2022;25(1):3\u20139.","journal-title":"Value Health"},{"key":"826_CR43","unstructured":"JAID\/JSC Infectious Disease Treatment Guide Guideline Formulation Committee. JAID\/JSC Infectious Disease Treatment Guide = The JAID\/JSC guide to clinical management of infectious diseases. 2019."},{"key":"826_CR44","unstructured":"Organization for Economic Cooperation and Development. OECD Data Exchange rates 2022. Available from: https:\/\/data.oecd.org\/conversion\/exchange-rates.htm. Accessed 1 Apr 2023."},{"key":"826_CR45","unstructured":"Medical Data Vision. Available from: https:\/\/en.mdv.co.jp\/. Accessed 1 Apr 2023."},{"key":"826_CR46","unstructured":"Ministry of Health Labour and Welfare, Japan Nosocomial Infections Surveillance. Data on file (Patient identifiers were de-identified by each facility before submission to JANIS. approval number: 0628\u20134). 2020."},{"key":"826_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.813145","volume":"12","author":"L Huang","year":"2021","unstructured":"Huang L, Huang C, Yan Y, Sun L, Li H. Urinary tract infection etiological profiles and antibiotic resistance patterns varied among different age categories: a retrospective study from a tertiary general hospital during a 12-year period. Front Microbiol. 2021;12: 813145.","journal-title":"Front Microbiol"},{"key":"826_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jgar.2021.09.018","volume":"29","author":"C Liu","year":"2022","unstructured":"Liu C, Xu M, Li X, Dong H, Ming L. Trends in antimicrobial resistance in bloodstream infections at a large tertiary-care hospital in China: a 10-year retrospective study (2010\u20132019). J Glob Antimicrob Resist. 2022;29:413\u20139.","journal-title":"J Glob Antimicrob Resist"},{"key":"826_CR49","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.2147\/IDR.S182180","volume":"11","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhao C, Chen H, Li H, Wang Q, Wang Z, et al. A multicenter epidemiology study on the risk factors and clinical outcomes of nosocomial intra-abdominal infections in China: results from the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) 2007\u20132016. Infect Drug Resist. 2018;11:2311\u20139.","journal-title":"Infect Drug Resist"},{"key":"826_CR50","unstructured":"National Institute of Population and Social Security Research. Life tables 2020 (Age 75\u201379). Available from: https:\/\/www.ipss.go.jp\/p-toukei\/JMD\/00\/STATS\/bltper_5x1.txt. Accessed 1 Apr 2023."},{"issue":"5","key":"826_CR51","doi-asserted-by":"publisher","first-page":"ofac133","DOI":"10.1093\/ofid\/ofac133","volume":"9","author":"TM Wozniak","year":"2022","unstructured":"Wozniak TM, Dyda A, Lee X. The increased length of hospital stay and mortality associated with community-associated infections in Australia. Open Forum Infect Dis. 2022;9(5):ofac133.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"826_CR52","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/1469-0691.12236","volume":"20","author":"M Pinholt","year":"2014","unstructured":"Pinholt M, Ostergaard C, Arpi M, Bruun NE, Sch\u00f8nheyder HC, Gradel KO, et al. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006\u20132009: a population-based cohort study. Clin Microbiol Infect. 2014;20(2):145\u201351.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"826_CR53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-019-2581-8","volume":"23","author":"AC Morvan","year":"2019","unstructured":"Morvan AC, Hengy B, Garrouste-Orgeas M, Ruckly S, Forel JM, Argaud L, et al. Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care-an analysis of the OUTCOMEREA database. Crit Care. 2019;23(1):307.","journal-title":"Crit Care"},{"issue":"8","key":"826_CR54","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jval.2021.03.010","volume":"24","author":"T Shiroiwa","year":"2021","unstructured":"Shiroiwa T, Noto S, Fukuda T. Japanese population norms of EQ-5D-5L and health utilities index mark 3: disutility catalog by disease and symptom in community settings. Value Health. 2021;24(8):1193\u2013202.","journal-title":"Value Health"},{"key":"826_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1477-7525-3-45","volume":"3","author":"EJ Ernst","year":"2005","unstructured":"Ernst EJ, Ernst ME, Hoehns JD, Bergus GR. Women\u2019s quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. Health Qual Life Outcomes. 2005;3:45.","journal-title":"Health Qual Life Outcomes"},{"key":"826_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00095-17","author":"EE Pliakos","year":"2018","unstructured":"Pliakos EE, Andreatos N, Shehadeh F, Ziakas PD, Mylonakis E. The cost-effectiveness of rapid diagnostic testing for the diagnosis of bloodstream infections with or without antimicrobial stewardship. Clin Microbiol Rev. 2018. https:\/\/doi.org\/10.1128\/CMR.00095-17.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"826_CR57","first-page":"23","volume":"184","author":"KJ Brasel","year":"1997","unstructured":"Brasel KJ, Borgstrom DC, Weigelt JA. Cost-utility analysis of contaminated appendectomy wounds. J Am Coll Surg. 1997;184(1):23\u201330.","journal-title":"J Am Coll Surg"},{"key":"826_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy9040175","author":"MJ Wingler","year":"2021","unstructured":"Wingler MJ, Patel NR, King ST, Wagner JL, Barber KE, Stover KR. Linezolid for the treatment of urinary tract infections caused by vancomycin-resistant enterococci. Pharmacy (Basel). 2021. https:\/\/doi.org\/10.3390\/pharmacy9040175.","journal-title":"Pharmacy (Basel)"},{"issue":"3","key":"826_CR59","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jhm.994","volume":"7","author":"JD Twilla","year":"2012","unstructured":"Twilla JD, Finch CK, Usery JB, Gelfand MS, Hudson JQ, Broyles JE. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin. J Hosp Med. 2012;7(3):243\u20138.","journal-title":"J Hosp Med"},{"issue":"6","key":"826_CR60","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1159\/000522259","volume":"40","author":"S Quickert","year":"2022","unstructured":"Quickert S, W\u00fcrstle S, Reuken PA, Hagel S, Schneider J, Schmid RM, et al. Real-world effectiveness of piperacillin\/tazobactam with and without linezolid for spontaneous bacterial peritonitis. Dig Dis. 2022;40(6):777\u201386.","journal-title":"Dig Dis"},{"key":"826_CR61","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/01.idc.0000144898.12957.eb","volume":"12","author":"KG Naber","year":"2004","unstructured":"Naber KG, Eisenstein BI, Tally F. Daptomycin versus ciprofloxacin in the treatment of complicated urinary tract infection due to gram-positive bacteria. Infect Dis Clin Pract. 2004;12:322\u20137.","journal-title":"Infect Dis Clin Pract"},{"issue":"4","key":"826_CR62","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/hep.27941","volume":"63","author":"S Piano","year":"2016","unstructured":"Piano S, Fasolato S, Salinas F, Romano A, Tonon M, Morando F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial. Hepatology. 2016;63(4):1299\u2013309.","journal-title":"Hepatology"},{"key":"826_CR63","unstructured":"Ministry of Health Labour and Welfare. Diagnostic Procedure Classification (DPC) electronic score table 2022. Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000198757_00004.html. Accessed 1 Apr 2023."},{"key":"826_CR64","unstructured":"Ministry of Health Labour and Welfare. Japan Medical Fee Points 2022. Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000188411_00037.html. Accessed 1 Apr 2023."},{"issue":"7","key":"826_CR65","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1053\/apmr.2002.32733","volume":"83","author":"WE Trick","year":"2002","unstructured":"Trick WE, Temple RS, Chen D, Wright MO, Solomon SL, Peterson LR. Patient colonization and environmental contamination by vancomycin-resistant enterococci in a rehabilitation facility. Arch Phys Med Rehabil. 2002;83(7):899\u2013902.","journal-title":"Arch Phys Med Rehabil"},{"key":"826_CR66","unstructured":"Center for Outcomes Research and Economic Evaluation for Health. Guideline for Preparing Cost-Effectiveness Evaluation to the Central Social Insurance Medical Council. Version 3.0. 2022. Available from: https:\/\/c2h.niph.go.jp\/tools\/guideline\/guideline_en.pdf. Accessed 1 Apr 2023."},{"issue":"1","key":"826_CR67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jval.2019.10.005","volume":"23","author":"M Hasegawa","year":"2020","unstructured":"Hasegawa M, Komoto S, Shiroiwa T, Fukuda T. Formal implementation of cost-effectiveness evaluations in Japan: a unique health technology assessment system. Value Health. 2020;23(1):43\u201351.","journal-title":"Value Health"},{"issue":"10","key":"826_CR68","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.ajic.2019.12.006","volume":"48","author":"D Morii","year":"2020","unstructured":"Morii D, Tomono K, Imanaka Y. Economic impact of antimicrobial-resistant bacteria outbreaks on Japanese hospitals. Am J Infect Control. 2020;48(10):1195\u20139.","journal-title":"Am J Infect Control"},{"issue":"1","key":"826_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2047-2994-2-18","volume":"2","author":"L Escaut","year":"2013","unstructured":"Escaut L, Bouam S, Frank-Soltysiak M, Rudant E, Saliba F, Kassis N, et al. Eradication of an outbreak of vancomycin-resistant Enterococcus (VRE): the cost of a failure in the systematic screening. Antimicrob Resist Infect Control. 2013;2(1):18.","journal-title":"Antimicrob Resist Infect Control"},{"key":"826_CR70","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13756-019-0628-x","volume":"8","author":"S Mac","year":"2019","unstructured":"Mac S, Fitzpatrick T, Johnstone J, Sander B. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis. Antimicrob Resist Infect Control. 2019;8:168.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"826_CR71","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2307\/30141528","volume":"19","author":"KK Lai","year":"1998","unstructured":"Lai KK, Kelley AL, Melvin ZS, Belliveau PP, Fontecchio SA. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect Control Hosp Epidemiol. 1998;19(9):647\u201352.","journal-title":"Infect Control Hosp Epidemiol"}],"updated-by":[{"DOI":"10.1007\/s40121-023-00853-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:00:00Z","timestamp":1693094400000}}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-023-00826-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-023-00826-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-023-00826-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T07:14:34Z","timestamp":1693206874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-023-00826-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1007\/s40121-023-00826-w","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40121-023-00853-7","asserted-by":"object"}]},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"4 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40121-023-00853-7","URL":"https:\/\/doi.org\/10.1007\/s40121-023-00853-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}